Since we observed TMIGD2 expression in CD34- cells from a small subset of AML patients whose CD34 expression was limited, we investigated whether TMIGD2 could enrich for functional LSCs in CD34- AML. The gene discussed is CD34; the disease is acute myeloid leukemia.